Physician profile
Jaffer Bashey
NPI 1801820139
$5,706.71
in general payments reported to CMS, 2019-2025
43 companies · $351 in 2025
The $351 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,513 · 2020: $342 · 2022: $352 · 2023: $1,744 · 2024: $1,404 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,320 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,319.93 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $938.07 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $601.00 | 2019-2024 | Erleada |
| Sumitomo Pharma America, INC. | $519.50 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $436.25 | 2019-2025 | |
| Boston Scientific Corporation | $407.97 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Moses 550 Dfl |
| Abbvie INC. | $325.24 | 2019-2024 | Botox, Lupron Depot |
| Dendreon Pharmaceuticals LLC | $220.36 | 2019-2024 | Provenge |
| Astrazeneca Pharmaceuticals LP | $166.75 | 2023-2024 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $153.40 | 2019-2024 | |
| 180 Medical, INC. | $142.25 | 2023-2025 | Cure Catheter, Gentlecath |
| Accord Healthcare, INC. | $131.21 | 2023-2024 | |
| Rochester Medical Corporation | $127.42 | 2022 | |
| Allergan, INC. | $110.58 | 2019-2020 | |
| Tolmar, INC. | $109.82 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $104.05 | 2023-2024 | Prolaris, Myrisk |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $102.23 | 2019-2024 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $102.02 | 2019-2024 | Yonsa |
| Medtronic, INC. | $99.04 | 2025 | Interstim |
| Healthtronics Stone Solutions, LLC | $93.60 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $86.18 | 2023-2024 | Lynparza, Keytruda |
| Verity Pharmaceuticals INC. | $85.83 | 2024 | Trelstar |
| Urogen Pharma, INC. | $74.62 | 2022-2024 | Jelmyto |
| Laborie Medical Technologies Corp. | $64.76 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $53.03 | 2019-2023 | Xgeva |
| Endo Pharmaceuticals INC. | $46.44 | 2019-2023 | Aveed, Xiaflex |
| Coloplast Corp | $36.49 | 2019-2020 | |
| Smith+Nephew, INC. | $32.09 | 2022 | |
| Calyxo, INC. | $30.54 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $28.60 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $27.38 | 2024 | Bard Urinary Drainage Bag |
| Ambu INC. | $26.44 | 2023 | |
| Dornier Medtech America, INC | $26.21 | 2020 | |
| Agiliti Surgical, INC. | $24.58 | 2019 | |
| Procept Biorobotics Corporation | $23.80 | 2024 | Aquabeam System |
| Antares Pharma, INC. | $23.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.15 | 2024 | |
| Novo Nordisk INC | $20.51 | 2024 | |
| Immunitybio, INC. | $18.43 | 2024 | |
| Janssen Scientific Affairs, LLC | $18.06 | 2019 | |
| Teleflex LLC | $14.44 | 2025 | Barrigel |
| Innovation Technologies INC | $14.31 | 2023 | Irrisept |
| Tempus Ai, INC | $14.11 | 2024 | |
| Travere Therapeutics, INC. | $3.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaffer Bashey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.